Acute mountain sickness score and hypoxemia

Journal of the Pakistan Medical Association

Volumn 51, Issue 5, 2001, Pages 173-179

  Hussain, M M ^a   Aslam, M ^a   Khan, Z ^a  

^a ARMY MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; MULTIVITAMIN;

ADULT; ALTITUDE DISEASE; ARTICLE; BLOOD GAS ANALYSIS; CARBON DIOXIDE TENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPOXEMIA; MALE; NORMAL HUMAN; OXYGEN TENSION; RANDOMIZED CONTROLLED TRIAL;

ACETAZOLAMIDE; ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; ANOXEMIA; DEVELOPING COUNTRIES; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; MALE; PAKISTAN;

EID: 0034959163     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Singh I , Khanna PK , Sri Vastava MC , et al. Acute Mountain Sickness. N. Engl. J. Med., 1969 ; 280 : 175-84.
2. Foster PJG. Effect of different ascent profiles on performance at 4200m elevation. Aviat Space Environ. Med., 1985 ; 5 : 758-64.
3. Hackett PH , Rennie D. The incidence , importance and prophylaxis of acute mountain sickness. Lancet, 1976 ; 2 : 1149-54.
4. Hackett PH and Roach RC. Medical therapy of altitude illness. Ann. Emerg. Med., 1987 ; 16 : 980 -6.
5. Ward MP, Milledge JS and West JB. High Altitude Medicine and Physiology. 2nd ed. London, Chapman and Hall Medical, 1995, p. 371.
6. Meechan RT and DC. The pathophysiology of acute high altitude illness Am. J. Med., 1982, 73 ; 395-403.
7. Cain SM, Dunn JE. Low doses of acetazolamide to aid accommodation of man to altitude. J. Appl. Physiol., 1966; 21: 1195-1200.
8. Swensen ER. Carbonic anhydrase inhibitors and acute mountain sickness. The News letter ISMM 1997 ; 7: 4 - 6.
9. Forrazzini G, Maggiorini M, Kriemler S et al. Successful treatment of acute mountain sickness with dexamethasone. Br. Med. J., 1987 ; 294 : 1380 -2.
10. Elleswerth AJ, Mayer EF, Larsen EB. Acetazolamide or dexamethasone use versus Placebo to prevent acute mountain sickness on Mount Rainier. West. J. Med., 1991 ; 154 : 289 -93.
11. Sampson JB, Kobrick JL. The Environment Symptoms Questionnaire Revisions and field data . Aviat. Space Environ. Med., 1980 ; 51 : 872-7.
12. Sampson JB , Cymerman A ,Burse RL , et al. Procedures for the measurement of acute mountain sickness. Aviat. Space Environ. Med., 1983 ; 54 : 1063-67.
13. Houston CS. Operation Everest One and Two : Studies of acclimatization to simulated high altitude. Respiration, 1997; 64 : 398 -406.
14. Fletcher RF , Wright AD , Jones GT et al. The clinical assessment of Acute Mountain Sickness. Q. J. Med., 1985; 54 ; 91-100.
15. Hackett PH, Oelz. The Lake Louise Consensus on the definition and amplification of altitude illness,in, Hypoxia and Mountain Medicine , eds , Sutton JR , et al, Burlington, Queen City Printers, 1992;pp. 327-80.
16. Milledge J. Ventilation in acute mountain sickness. Int Congress of Mountain Med (Absract Book), 1997 ; 12 -14.
17. Bernhard W, Miller L, Villarreal J. Cerebral symptoms of high altitude : preventive effects of acetazolamide-dexamethasone versus acetazolamide alone. in: Hypoxia and Mountain medicine eds Sutton JR, Coates G and Houston CS Burlington, Queen Printers, 1992;p. 294.
18. Swenson ER, Leatham KL, Roach RC et al. Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir. physiol., 1991; 86:333-43.
19. Elleswerth AJ; Larsen EB and Stricklad D. A randomized trial of dexamethasone and acetazolamide for AMS. Am J. Med., 1987; 83 : 1024-30.
20. Birmingham Medical Research Expeditionary Society Mountain Study Group. Acetazolamide in control of Acute Mountain Sickness. Lancet, 1981; 1: 180-3.
21. Burki NK , Khan SA, Hameed MA. The effects of Acetazolamide on ventilatory response to high altitude hypoxia. Chest, 1992 ; 101: 736-41.
22. Bradwell AR , Dykes PW and Coote JH . Effect of acetazolamide on exercise performance and muscle mass at high altitude. Lancet, 1986;1:1001-5.
23. Johnson TS, Rock PB, Fulco CS, et al. Prevention of Acute Mountin Sickness by Dexamethasone. N. Engl. J. Med., 1984 : 310 ; 683 - 6.
24. Berghold F. Recommendations for acclimatisation, in, Proc. Int. Congress of Mountain. Switzerland, Med Casino Kursaal, Aug 27 - 30,1997; pp. 25 - 26.
25. Maren TH. Carbonic anhydrase : Chemistry , Physiology and inhibition. Physiol, Rev., 1967; 47 : 595 - 781.
26. Cain SM, Dunn JE. Low doses of acetazolamide to aid accomodation of man to altitude. J. Appl. Physiol., 1966 ; 21 : 1195 - 1200.
27. Keller HR , Maggiorini M, Bartsch P et al. Simulated descent versus dexamethasone in treatment of acute mountain sickness : a randomized trial. Br. Med. J., 1995 ; 310 : 1232 - 35
28. Maher JT , Cymerman A , Reeves JT . Acute mountain sickness : Increased severity in eucapnic hypoxia. Aviat. Space. Environ. Med., 1975 ; 46 : 826 -9.
29. Basmyat B, Lemaster J and Litch JA. Everest or BUST. A cross-sectional, Epidemiological study of Acute Mountain Sickness at 4243 meters in Himalaya. Aviat Space Environ. Med., 1999 ; 70:867-73.
30. Maher JT; Cymerman A, Reeves JT et al. Acute mountain sickness: Increased severity in eucapnic hypoxia. Aviat. space Environ. Med., 1975; 46:826-9.
31. Johnson TS and Rock PB. Acute Mountain Sickness. N. Engl. J. Med., 1988: 319 : 841-5.
32. Coote JH. Medicine and Mechanisms in altitude sickness : Recommendations. Sports Med., 1995 ; 20: 148 - 59.